首页> 美国卫生研究院文献>other >A Phase II Clinical Trial Of Oral Bropirimine In Combination With Intravesical Bacillus Calmette -Guerin For Carcinoma In Situ (CIS) Of The Bladder A Southwest Oncology Group Study

【2h】

A Phase II Clinical Trial Of Oral Bropirimine In Combination With Intravesical Bacillus Calmette -Guerin For Carcinoma In Situ (CIS) Of The Bladder A Southwest Oncology Group Study

机译：口服溴虫嘧啶与膀胱内芽孢杆菌卡介苗联合治疗膀胱原位癌（CIS）的第二阶段临床试验西南肿瘤小组研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives:To estimate the probability of response when intravesical BCG is given in combination with oral bropirimine for bladder carcinoma in-situ, and to evaluate toxicity when the two agents are combined.

机译：目的：评估膀胱内卡介苗联合口服溴哌啶胺联合原位治疗膀胱癌的反应可能性，并评估两种药物联合使用时的毒性。

著录项

期刊名称 other
作者
Michael F. Sarosdy; Catherine M. Tangen; Geoffrey R. Weiss; Blake R. Nestok; Mitchell C. Benson; Paul F. Schellhammer; Arthur I. Sagalowsky; David P. Wood Jr.; E. David Crawford;
展开▼
作者单位

展开▼
年(卷),期 -1(23),6
年度 -1
页码 386–389
总页数 7
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献

1. A phase II clinical trial of oral bropirimine in combination with intravesical bacillus Calmette-Guerin for carcinoma in situ of the bladder: a Southwest Oncology Group Study. [J] . Sarosdy MF, Tangen CM, Weiss GR, Urologic oncology . 2005,第6期

机译：口服溴哌啶胺联合膀胱内芽孢杆菌卡介苗治疗膀胱原位癌的II期临床试验：西南肿瘤小组研究。
2. Phase II study of intravesical therapy with AD32 in patients with papillary urothelial carcinoma or carcinoma in situ (CIS) refractory to prior therapy with bacillus Calmette-Guerin (E3897): a trial of the Eastern Cooperative Oncology Group. [J] . Ignatoff JM, Chen YH, Greenberg RE, Urologic oncology . 2009,第5期

机译：乳头尿路上皮癌或原位癌（CIS）难以治疗的乳头尿路上皮癌或原位癌（CIS）患者进行AD32膀胱内治疗的II期研究：东方合作肿瘤小组的一项试验。
3. Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guerin and with bacillus Calmette-Guerin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993). [J] . Oosterlinck W, Kirkali Z, Sylvester R, European urology . 2011,第3期

机译：膀胱原位癌患者使用丝裂霉素C和芽孢杆菌Calmette-Guerin以及单独使用芽孢杆菌Calmette-Guerin的顺序膀胱内化学免疫治疗：EORTC生殖泌尿泌尿系统小组2期随机试验的结果（30993）。
4. Determination of Bacillus Calmette-Guerin Concentration Integrated in Delivery Materials for Intravesical Infusion Therapy of Superficial Bladder Cancer [C] . Chengge Wu, Kangning Sun, Aimin Li International Conference on Advances in Materials and Manufacturing . 2013

机译：浅析浅析浅表膀胱癌膀胱内输液治疗
5. Clinical predictive value of pre-clinical cancer models: A study of the predictive value of the in vitro cell line, human xenograft and murine allograft pre-clinical cancer models for phase II clinical trials of cytotoxic cancer drugs [D] . Voskoglou-Nomikos, Theodora 2001

机译：临床前癌症模型的临床预测价值：体外细胞系，人异种移植和小鼠同种异体移植临床前癌症模型对细胞毒性癌症药物II期临床试验的预测价值研究
6. Phase II Study of Intravesical Therapy with AD32 in Patients with Papillary Urothelial Carcinoma or Carcinoma in situ (CIS) Refractory to Prior Therapy with Bacillus Calmette-Guerin (E3897): A Trial of the Eastern Cooperative Oncology Group [O] . Jeffrey M. Ignatoff, Yu-Hui Chen, Richard Evan Greenberg, -1

机译：乳头状尿路上皮癌或原位癌（CIS）难以治愈的乳头状上皮癌或原位癌（CIS）的膀胱内治疗AD32的II期研究：东部合作肿瘤小组的一项试验
7. A Randomized study of intravesical mitomycin C, bacillus Calmette-Guerin TICE and bacillus Calmette-Guerin RIVM treatment in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder [O] . Vegt P.D.J., Witjes J.A., Witjes W.P.J., 1995

机译：膀胱丝裂霉素C，卡介苗芽孢杆菌TICE和卡介苗芽孢杆菌RIVM治疗pTa-pT1乳头状癌和膀胱原位癌的随机研究

A Phase II Clinical Trial Of Oral Bropirimine In Combination With Intravesical Bacillus Calmette -Guerin For Carcinoma In Situ (CIS) Of The Bladder A Southwest Oncology Group Study

摘要

著录项

相似文献

相关主题

期刊订阅